Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis
INTRODUCTION: The JAK2V617F mutation is present in the majority of patients with essential thrombocythemia (ET) and primary myelofibrosis (PMF). The impact of this mutation on disease phenotype in ET and PMF is still a matter of discussion. This study aims to determine whether there are differences...
Main Authors: | İpek Yonal, Aynur Dağlar Aday, Başak Akadam Teker, Ceylan Yılmaz, Meliha Nalcacı, Akif Selim Yavuz, Fatma Deniz Sargın |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2016-05-01
|
Series: | Turkish Journal of Hematology |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-05025 |
Similar Items
-
JAK2 V617F prevalence in Brazilian patients with polycythemia vera, idiopathic myelofibrosis and essential thrombocythemia
by: Bárbara da Costa Reis Monte-Mór, et al.
Published: (2007-03-01) -
Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms
by: İpek Yonal Hindilerden, et al.
Published: (2023-08-01) -
Development and validation of a model for the early prediction of progression from essential thrombocythemia to post-essential thrombocythemia myelofibrosis: a multicentre retrospective studyResearch in context
by: Danhong Xiang, et al.
Published: (2024-01-01) -
LUNG CLEAR “SUGAR” CELL TUMOR AND JAK V617F POSITIVE ESSENTIAL THROMBOCYTHEMIA: COINCIDENCE
by: Volkan Yazak, et al.
Published: (2014-08-01) -
Management of paroxysmal nocturnal hemoglobinuria in CALR mutated post‐essential thrombocythemia myelofibrosis: A case report
by: Mahija Cheekati, et al.
Published: (2024-04-01)